Diabetes Stoffwechsel und Herz

Scope & Guideline

Illuminating the Complex Interactions Between Metabolism and Heart Health

Introduction

Welcome to your portal for understanding Diabetes Stoffwechsel und Herz, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageGerman
ISSN1861-7603
PublisherVERLAG KIRCHHEIM
Support Open AccessNo
Country-
TypeJournal
Convergefrom 2006 to 2017 (coverage discontinued in Scopus)
AbbreviationDIABETES STOFFWECH H / Diabetes Stoffwech. Herz
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPOSTFACH 25 24, MAINZ 55015, GERMANY

Aims and Scopes

The journal 'Diabetes Stoffwechsel und Herz' is dedicated to advancing knowledge and understanding of diabetes and its interconnections with cardiovascular health. It serves as a platform for researchers and clinicians to share their findings and insights, focusing on the latest developments in diabetes management, cardiovascular complications, and innovative treatment approaches.
  1. Diabetes Management and Treatment Innovations:
    The journal emphasizes new methodologies and advancements in diabetes care, including novel insulin therapies, continuous glucose monitoring technologies, and personalized diabetes management strategies.
  2. Cardiovascular Health in Diabetes:
    A core focus is the relationship between diabetes and cardiovascular diseases, exploring how diabetes impacts heart health and the implications for treatment and prevention.
  3. Metabolic and Endocrine Interactions:
    Research addressing the complex interplay between diabetes, metabolic syndrome, and endocrine disorders is prevalent, contributing to a deeper understanding of patient care.
  4. Technological Advances in Diabetes Care:
    The journal features studies on the integration of technology in diabetes management, such as artificial intelligence applications and smart insulin delivery systems, showcasing innovative solutions to enhance patient outcomes.
  5. Public Health and Policy Perspectives:
    It also addresses broader public health issues and policy implications related to diabetes and cardiovascular disease, promoting interdisciplinary approaches to disease prevention and management.
Recent publications indicate several emerging themes and trends that reflect the evolving landscape of diabetes research and management, highlighting areas of growing interest and innovation.
  1. Artificial Intelligence and Data Analytics:
    The integration of AI in diabetes management is a prominent trend, with studies exploring its potential to enhance monitoring, predict complications, and personalize treatment.
  2. Cardiorenal Interactions:
    Research focusing on the connections between diabetes, kidney function, and heart health is on the rise, emphasizing the importance of integrated care approaches for these interconnected conditions.
  3. Personalized Medicine and Patient-Centric Approaches:
    Emerging themes include the customization of diabetes treatment plans based on individual patient profiles, including genetic, lifestyle, and metabolic considerations.
  4. Innovations in Diabetes Technology:
    Technological advancements such as smart insulin pens, continuous glucose monitoring systems, and telemedicine are increasingly featured, reflecting a shift towards more patient-friendly management options.
  5. Psychosocial Aspects of Diabetes Management:
    There is a growing recognition of the psychological and social dimensions of diabetes care, with research exploring how these factors influence patient adherence and overall health outcomes.

Declining or Waning

While the journal maintains a strong focus on diabetes and cardiovascular health, certain themes appear to be declining in prominence. This may reflect shifts in research priorities or advancements that have rendered previous topics less critical.
  1. Traditional Therapeutic Approaches:
    There has been a noticeable decline in papers focusing solely on traditional diabetes therapies, such as standard insulin regimens, as newer and more effective treatments gain attention.
  2. Basic Science of Diabetes:
    Research centered on the fundamental biological mechanisms of diabetes, while still important, has seen less frequency compared to applied clinical research and technology-focused studies.
  3. Chronic Complications of Diabetes:
    While chronic complications remain a critical area, specific discussions on complications like neuropathy and retinopathy appear to be less frequent, possibly overshadowed by more immediate cardiovascular concerns.

Similar Journals

DIABETES CARE

Transforming knowledge into diabetes care solutions.
Publisher: AMER DIABETES ASSOCISSN: 0149-5992Frequency: 12 issues/year

DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.

Diabetes Therapy

Transforming diabetes management with cutting-edge insights.
Publisher: SPRINGER HEIDELBERGISSN: 1869-6953Frequency: 6 issues/year

Diabetes Therapy is a prominent open access journal published by SPRINGER HEIDELBERG, dedicated to advancing our understanding of diabetes management and therapeutic strategies. Since its inception in 2010, the journal has provided a platform for high-quality research, showcasing innovative studies and clinical advances aimed at improving care for individuals with diabetes. With an established impact factor and categorized within the Q2 quartile in both Endocrinology, Diabetes and Metabolism and Internal Medicine in 2023, it ranks among the top journals in its field, reflecting its significant contribution to medical knowledge. Researchers, healthcare professionals, and students benefit from its comprehensive coverage of critical topics, ranging from pharmacological advancements to lifestyle interventions and cutting-edge technologies in diabetes management. With a Scopus rank placing it 35th in Internal Medicine, and 68th in Endocrinology, Diabetes, and Metabolism, Diabetes Therapy is recognized for its robust peer-reviewed content, making it an essential resource for anyone engaged in diabetes research and care.

DIABETES & METABOLISM

Transforming Insights into Metabolic Disease Solutions
Publisher: MASSON EDITEURISSN: 1262-3636Frequency: 6 issues/year

DIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.

ACTA DIABETOLOGICA

Pioneering Research in Endocrinology and Diabetes
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 0940-5429Frequency: 12 issues/year

ACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.

HORMONE AND METABOLIC RESEARCH

Advancing Knowledge in Endocrinology and Biochemistry
Publisher: GEORG THIEME VERLAG KGISSN: 0018-5043Frequency: 12 issues/year

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

Cardiovascular Endocrinology & Metabolism

Unlocking the Connections Between Heart and Hormonal Health
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2574-0954Frequency: 4 issues/year

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.

Journal of Diabetes

Connecting knowledge with innovative diabetes solutions.
Publisher: WILEYISSN: 1753-0393Frequency: 12 issues/year

The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo

Connecting research and practice in diabetes care.
Publisher: SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDMISSN: 1646-3439Frequency: 2 issues/year

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

Journal of Diabetes Research

Exploring breakthroughs in diabetes science.
Publisher: HINDAWI LTDISSN: 2314-6745Frequency:

Journal of Diabetes Research, published by HINDAWI LTD, is a leading open-access journal dedicated to advancing the understanding and management of diabetes. Established in 2013, the journal has swiftly gained recognition, achieving a commendable Q2 ranking in both the categories of Endocrinology and Diabetes and Metabolism, as well as in Biochemistry, Genetics and Molecular Biology. With an impressive Scopus ranking of #42 out of 244 in its field, the journal provides a platform for cutting-edge research that addresses the multifaceted challenges posed by diabetes. Offering unrestricted access to its articles since its inception, the journal aims to foster collaboration and exchange of innovative ideas among researchers, clinicians, and students worldwide. It is particularly vital for those engaged in diabetes research, as it publishes influential studies that impact clinical practices and enhance patient outcomes. For academics and professionals seeking to contribute to the growing body of knowledge in diabetes, the Journal of Diabetes Research serves as a valuable resource.

Current Opinion in Endocrinology Diabetes and Obesity

Illuminating Trends in Endocrinology and Diabetes Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1752-296XFrequency: 6 issues/year

Current Opinion in Endocrinology, Diabetes and Obesity, published by LIPPINCOTT WILLIAMS & WILKINS, offers a critical analysis of the latest advancements and trends in the fields of endocrinology, diabetes, and obesity. With an ISSN of 1752-296X and an E-ISSN of 1752-2978, this esteemed journal provides an authoritative platform for researchers, clinicians, and healthcare professionals to stay updated on emerging research and clinical practices. Renowned for its impactful contributions, the journal holds notable rankings, including Q2 in Endocrinology and Diabetes & Metabolism, as well as a commendable Q1 in Internal Medicine, reflecting its significance in the academic community. Although currently not an open access publication, articles published from 2007 to 2024 continually enrich the discourse on pressing health issues related to endocrinology and metabolic disorders. By fostering a comprehensive understanding of the complexities within these interconnected fields, it serves as an essential resource for any professional or student engaged in health science research.